Today: 10 June 2026
Shopify stock slips as insider sale filing lands and earnings loom next week
6 February 2026
2 mins read

Shopify stock slips as insider sale filing lands and earnings loom next week

NEW YORK, Feb 6, 2026, 14:13 EST — Regular session trading underway.

  • Shopify dropped about 1% around midday.
  • A director has filed a Rule 144 notice for the planned sale of 1,200 shares.
  • Investors are positioning themselves before Shopify reports earnings and updates its outlook on Feb. 11.

Shopify Inc shares slipped Friday, bucking the upward move in U.S. equities. Investors eyed news of an insider planning to sell shares and continued to show caution toward high-growth software names. The stock lost 0.9% to $110.19 by 2:13 p.m. EST, after touching $114.98 earlier.

Shopify’s slide comes only days before the company is due to report both fourth-quarter and full-year results. The numbers are scheduled to hit before the U.S. market opens on Feb. 11. Management will follow up with an earnings call at 8:30 a.m. ET.

Investors watched tech shares slide, unnerved just before a packed stretch of economic releases. Wednesday brings the U.S. jobs report; consumer inflation data lands Friday. Both were pushed back due to the government shutdown. “Rotation is the dominant theme this year,” said Angelo Kourkafas, senior global investment strategist at Edward Jones, pointing to the exit from tech-heavy trades. Reuters

Director Gail Goodman is looking to unload 1,200 Class A shares, according to a Form 144, with Morgan Stanley Smith Barney handling the sale. The batch is worth $136,824. Goodman picked up the shares back on Feb. 5 by exercising stock options, the filing says. It also mentions earlier 10b5-1 sales over the past three months.

Rule 144 gives insiders a way to signal to the SEC their intent to unload restricted or control shares—as long as they stick to the required conditions. By contrast, a 10b5-1 plan lays out a pre-arranged trading system aimed at protecting against trades made while holding material non-public information.

Shopify’s gross merchandise volume (GMV)—the sum of goods sold through its platform—is going to draw plenty of scrutiny, along with its cut from payments, shipping, and merchant services. Investors are watching operating expenses and how aggressively Shopify is funding new products, particularly with attitudes souring on high-multiple software names.

Shopify carries a “Buy” consensus from analysts tracked by StockAnalysis, with a $167.48 average target for the next year. Price estimates, however, are all over the map—anywhere between $104 and $200. StockAnalysis

Shopify is getting caught up in what some are calling a “software-mageddon,” with shares under pressure as the market reacts to fears that fast-advancing AI could shake up the industry and compress multiples. “We’re seeing people de-risk from technology in a general way,” said Andrew Wells, chief investment officer at SanJac Alpha. Reuters

Stocks bounced back a bit Friday, clawing back ground after a rough stretch for tech. All three majors—the Dow, S&P 500, and Nasdaq—were up by late morning, even as Amazon slid on plans for sharply higher AI-related capital spending in 2026. The looming question: Will these AI bets deliver, or just squeeze software demand further? Jitters lingered.

Insider sales keep popping up, but the amounts are minor relative to Shopify’s massive float and rarely spark instant waves of selling. The real test lands next week: if Shopify’s guidance misses the high bar or management signals bigger spending in 2026, shares could drop fast.

Shopify is up next on Feb. 11, dropping earnings ahead of the open, with a Q&A slated for 8:30 a.m. ET. Next week’s U.S. jobs and inflation data also loom, numbers that can shake up growth stocks if they change the rate narrative.

Stock Market Today

  • NuScale Power Faces Sharp Share Decline Amid Valuation Debate
    June 10, 2026, 1:25 PM EDT. NuScale Power (SMR) shares have plunged 28% in the past week and nearly 39% year-to-date, sparking investor reassessment. Despite recent setbacks including project cancellations and regulatory hurdles common for first-of-its-kind technologies, some analysts see the stock as significantly undervalued, with a fair value estimate around $100 compared to the current $10 share price. NuScale's revenue stands at $18.7 million with a loss of $386 million, reflecting early-stage challenges but potential long-term growth tied to small modular reactor (SMR) adoption. The stock trades at about 3 times book value, above the U.S. electrical industry average but well below peers, indicating mixed market sentiment. Key risks include further regulatory delays and continued funding needs. Investors are advised to weigh near-term risks against the long-term nuclear energy infrastructure outlook.

Latest articles

BigBear.ai Stock Bounces as Shareholder Vote Squeeze Meets Panama AI Speculation

BigBear.ai Stock Bounces as Shareholder Vote Squeeze Meets Panama AI Speculation

10 June 2026
BigBear.ai shares rose 2.8% to $4.10 as investors weighed the approved move to double authorized shares to 1 billion, giving the company flexibility for financing but raising dilution risks, while the Panama cargo-security rollout and $281.9 million backlog keep growth hopes alive amid ongoing losses and revenue conversion questions.
Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

Cracker Barrel Jumps After Surprise Profit Forces Investors to Rethink Turnaround

10 June 2026
Cracker Barrel shares soared 26% after a surprise Q3 profit and raised 2026 revenue and adjusted EBITDA outlook, even as restaurant traffic stayed negative; investors focused on improved guidance and cost cuts, with Wells Fargo upgrading the stock and raising its price target to $50, but risks remain if guest counts don’t recover.
Lemonade Shares Jump as Investors Zero In on Profit Path

Lemonade Shares Jump as Investors Zero In on Profit Path

10 June 2026
Lemonade shares jumped 10.6% to an intraday high above $60 after CEO Daniel Schreiber and CFO Tim Bixby appeared at Morgan Stanley’s U.S. Financials Conference, as investors focused on the company’s reiterated target for positive adjusted EBITDA in Q4 and a fresh TD Cowen price target hike, with shrinking losses and improved underwriting driving optimism.
AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt
Previous Story

AbbVie stock rises as investors re-rank Rinvoq and Skyrizi after earnings jolt

Oracle stock rebounds after a bruising week — what traders are watching next for ORCL
Next Story

Oracle stock rebounds after a bruising week — what traders are watching next for ORCL

Go toTop